MCF Advisors’s CME Group CME Stock Holding History

MCF Advisors’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$168K	Sell	759 -22	-3%	-$6.09K	0.01%	458
2026 Q1	$231K	Buy	781 +415	+113%	+$123K	0.01%	377
2025 Q4	$99.9K	Buy	366 +16	+5%	+$4.35K	0.01%	405
2025 Q3	$94.6K	Buy	350 +12	+4%	+$3.27K	0.01%	328
2025 Q2	$93.2K	Hold	338	–	–	0.01%	319
2025 Q1	$89.7K	Sell	338 -20	-6%	-$4.93K	0.01%	322
2024 Q4	$84.7K	Buy	358 +73	+26%	+$16.8K	0.01%	333
2024 Q3	$62.9K	Sell	285 -3	-1%	-$621	﹤0.01%	359
2024 Q2	$56.6K	Hold	288	–	–	﹤0.01%	362
2024 Q1	$62K	Buy	288 +3	+1%	+$630	﹤0.01%	348
2023 Q4	$61.4K	Buy	285 +60	+27%	+$12.8K	0.01%	344
2023 Q3	$45K	Hold	225	–	–	﹤0.01%	369
2023 Q2	$41.7K	Hold	225	–	–	﹤0.01%	383
2023 Q1	$43.1K	Buy	225 +11	+5%	+$1.99K	﹤0.01%	375
2022 Q4	$36K	Sell	214 -464	-68%	-$80.6K	﹤0.01%	382
2022 Q3	$120K	Buy	678 +211	+45%	+$41.7K	0.01%	241
2022 Q2	$96K	Sell	467 -150	-24%	-$31.8K	0.01%	252
2022 Q1	$147K	Buy	+617	New	+$145K	0.01%	222
2021 Q4	–	Sell	-628	Closed	-$121K	–	157
2021 Q3	$121K	Buy	628 +161	+34%	+$32.6K	0.01%	229
2021 Q2	$99K	Buy	+467	New	+$98.6K	0.01%	232
2016 Q3	–	Sell	-17	Closed	-$2K	–	458
2016 Q2	$2K	Buy	+17	New	+$1.61K	﹤0.01%	459

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

MCF Advisors's CME Position: Q2 2026 in Review

MCF Advisors reduced its CME Group (CME) stake by 2.8% in Q2 2026, selling an estimated $6.09K and leaving 759 shares worth $168K. The position accounts for 0.01% of the portfolio, ranked #458.

MCF Advisors first reported a position in CME in Q2 2016 and has held it in 21 quarters since. The position peaked at $231K in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

MCF Advisors held 759 shares of CME Group worth $168K as of Q2 2026.
MCF Advisors sold 22 CME Group shares in Q2 2026, an estimated $6.09K.
CME Group made up 0.01% of MCF Advisors's portfolio in Q2 2026, its #458 holding.
MCF Advisors first reported a position in CME Group in Q2 2016 and has held it in 21 quarters since.
MCF Advisors's CME Group position peaked at $231K in Q1 2026.
1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.